Dashboard / Compare
Compare Formulations
Side-by-side release profile comparison.
Formulation A
AFormulation B
BVS
Release Profile Overlay
Cumulative release vs timeParameter Comparison
| Parameter | PLGA-DOX-NP-01 | CS-DOX-NP-02 | Difference |
|---|---|---|---|
| Nanocarrier | PLGA nanoparticles | Chitosan nanoparticles | — |
| Size (nm) | 180 | 250 | — |
| Drug loading (%) | 8.5 | 5.2 | Δ 3.3% |
| Best model | Korsmeyer-Peppas | Higuchi | — |
| R² | 0.9912 | 0.9801 | Δ 0.0111 |
| Release at 1 h (%) | 22.1 | 15.4 | A +6.7% |
| Release at 24 h (%) | 85.6 | 71.2 | A +14.4% |
| T50 (h) | 4.2 | 8.7 | A 2× faster |
| T80 (h) | 18.5 | 32.1 | A 1.7× faster |
| Burst release (%) | 12.3 | 8.1 | B lower burst |
Release speed
Formulation A reaches 50% release 2× faster than B.
Burst effect
Formulation B shows 34% lower burst release.
Sustained release
Formulation B maintains release over a longer period.
AI Comparison Summary
Mechanism insightFormulation A (PLGA) shows a faster initial release and higher burst effect (12.3% vs 8.1%), while Formulation B (Chitosan) shows slower sustained release. The PLGA formulation reaches 50% release at 4.2 hours compared to 8.7 hours for Chitosan, which may suggest different matrix properties and drug–polymer interactions. The lower burst release of the Chitosan formulation may be advantageous for applications requiring gradual onset.
AI summary placeholder — secure backend integration planned. Experimental validation required.